ArticleScientific reports2025
Prediction of suitable drug for keloid through analytic hierarchy process and topological indices.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of the study is to identify the most suitable drug in treating Keloid, from the considered drugs using Multi Criteria Decision Making (MCDM) technique, Analytic Hierarchy Process (AHP) via degree-based topological indices. Topological indices play a vital role in predicting the biological and physicochemical properties of chemical compounds by deriving them from the molecular structure using specific rules. Given the growing prevalence of keloid cases, there is an increasing need for safer and more effective drugs. This study investigates 12 keloid drugs by applying the QSPR technique with respect to their physicochemical properties. The drugs are ranked using the AHP with specific criteria, allowing for the identification of the most effective drug combinations to help in the development of improved treatments for keloids. From the analysis, it is observed that the most effective and suitable drug is Doxorubicin while the least effective drug is 5-Fluorouracil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.